ADPT Stock Analysis: Buy, Sell, or Hold?
ADPT - Adaptive Biotechnologies Corporation Common Stock
$18.50
0.13 (0.71%)
▲
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 10, 2026
10d
Get Alerted When ADPT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ADPT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ADPT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ADPT is currently trading at $18.50, which is considered extended relative to its 30-day fair value range of $16.34 to $18.47.
Technical Outlook: Technically, ADPT is in a strong uptrend. Immediate support is located at $16.55, while resistance sits at $19.42.
Market Sentiment: ADPT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ADPT is in a strong uptrend. Immediate support is located at $16.55, while resistance sits at $19.42.
Market Sentiment: ADPT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$16.34 -
$18.47
Company Quality Score
60/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
57.9%
Protect Your Profits
Holding ADPT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($20.14)
Fair Price Analysis
30-Day Fair Range
$16.34 -
$18.47
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$16.55
Resistance Level
$19.42
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-31.51
Wall Street Target
$20.14
(+9.7%)
Revenue Growth (YoY)
102.4%
Profit Margin
-31.5%
Last updated: January 30, 2026 5:51 PM ET
Data refreshes hourly during market hours. Next update: 6:51 PM
Data refreshes hourly during market hours. Next update: 6:51 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ADPT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$404 | 63 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$56 | 59 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$210 | 57 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 56 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 53 HOLD |
Advanced ADPT Option Strategies
Professional options setups generated by AI based on today's ADPT price and gamma walls.
